Molecular	O
characterization	O
of	O
angiogenic	O
properties	O
of	O
human	O
oral	B-Cell
squamous	I-Cell
cell	I-Cell
carcinoma	I-Cell
cells	I-Cell
.	O

Little	O
is	O
known	O
about	O
the	O
specificity	O
of	O
angiogenic	O
properties	O
of	O
oral	B-Cell
cancer	I-Cell
cells	I-Cell
and	O
the	O
possible	O
mechanisms	O
.	O

Stimulatory	O
effects	O
on	O
proliferation	O
and	O
migration	O
of	O
human	B-Cell
umbilical	I-Cell
vein	I-Cell
endothelial	I-Cell
cells	I-Cell
(	O
HUVEC	B-Cell
)	O
characterized	O
the	O
angiogenic	O
properties	O
of	O
oral	B-Cell
cancer	I-Cell
cells	I-Cell
but	O
not	O
normal	B-Cell
oral	I-Cell
keratinocytes	I-Cell
(	O
NOK	B-Cell
)	O
.	O

ELISA	O
found	O
the	O
presence	O
of	O
vascular	O
endothelial	O
growth	O
factors	O
(	O
VEGF	O
)	O
both	O
in	O
the	O
tested	O
oral	B-Cell
cancer	I-Cell
cells	I-Cell
and	O
NOK	B-Cell
.	O

Attenuation	O
of	O
the	O
proangiogenic	O
effects	O
by	O
neutralizing	O
VEGF	O
antibodies	O
suggests	O
VEGF	O
play	O
a	O
key	O
role	O
in	O
the	O
acquisition	O
of	O
the	O
angiogenic	O
phenotype	O
in	O
oral	B-Cell
cancer	I-Cell
cells	I-Cell
.	O

Western	O
blotting	O
of	O
p53	O
and	O
murine	O
double	O
mutant	O
2	O
(	O
Mdm2	O
)	O
together	O
with	O
p53	O
DNA	O
sequencing	O
analysis	O
indicate	O
that	O
p53	O
function	O
loss	O
by	O
mutation	O
or	O
overexpression	O
of	O
Mdm2	O
occurred	O
in	O
all	O
tested	O
oral	B-Cell
cancer	I-Cell
cells	I-Cell
regardless	O
of	O
their	O
etiology	O
.	O

In	O
summary	O
,	O
the	O
angiogenic	O
property	O
of	O
oral	B-Cell
cancer	I-Cell
cells	I-Cell
is	O
mediated	O
by	O
many	O
factors	O
in	O
addition	O
to	O
VEGF	O
and	O
the	O
functional	O
status	O
of	O
p53	O
.	O

